Arcutis Biotherapeutics, Inc. (ARQT)
19.50
-0.53
(-2.65%)
USD |
NASDAQ |
May 19, 16:00
19.50
0.00 (0.00%)
After-Hours: 16:31
Arcutis Biotherapeutics Shareholders Equity (Quarterly) : 189.65M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.248B |
| ADMA Biologics, Inc. | 390.32M |
| MannKind Corp. | -59.20M |
| PTC Therapeutics, Inc. | -180.46M |
| Ultragenyx Pharmaceutical, Inc. | -236.00M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 460.00M |
| Total Liabilities (Quarterly) | 270.36M |
| Debt to Equity Ratio | 0.6047 |
| Current Ratio | 2.684 |
| Net Debt Paydown Yield | -0.03% |